Zegalogue .6 mg/.6mL (Dasiglucagon INJECTION, SOLUTION) .6 mg/.6mL

Zegalogue 0.6 mg/0.6mL is a glucagon injection used for severe hypoglycemia. This solution is designed for subcutaneous administration, offering a reliable treatment option for low blood sugar emergencies.

Strength

.6 mg/.6mL

Pack Size

2 PACKAGE in 1 CARTON (0169-1913-02) / 1 CONTAINER in 1 PACKAGE (0169-1913-12) / 1 SYRINGE, GLASS

Manufacturer / TM Owner

Novo Nordisk

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zegalogue is primarily used to treat severe hypoglycemia, a condition characterized by dangerously low blood sugar levels. It works by raising blood glucose levels quickly, making it essential for individuals at risk of hypoglycemia, such as those with diabetes. The injection is administered subcutaneously, providing rapid relief in emergency situations.

Side Effects

Common effects of Zegalogue may include temporary nausea, vomiting, or headache. Some users might experience injection site reactions, such as redness or swelling. These effects are generally mild and short-lived, but any persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

Zegalogue should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed guidelines for use and to be aware of any potential allergic reactions. Always keep the medication out of reach of children and dispose of used syringes safely.

Avoid Interactions

Zegalogue may interact with certain medications, including beta-blockers and indomethacin. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect blood sugar levels should be used with caution.

Frequently Asked Questions

Zegalogue is used to treat severe hypoglycemia, helping to raise blood sugar levels quickly in emergency situations.

Zegalogue is administered subcutaneously, typically in the abdomen, thigh, or upper arm.

Common side effects may include nausea, vomiting, headache, and injection site reactions.

Zegalogue may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

Zegalogue should be stored at room temperature, away from light and moisture, and kept out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.